Option Care Health (NASDAQ:OPCH – Get Free Report) and Amplifon (OTCMKTS:AMFPF – Get Free Report) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.
Insider and Institutional Ownership
98.0% of Option Care Health shares are owned by institutional investors. 1.7% of Option Care Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Profitability
This table compares Option Care Health and Amplifon’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Option Care Health | 3.68% | 18.74% | 7.25% |
| Amplifon | 3.01% | 15.03% | 4.29% |
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Option Care Health | 1 | 6 | 7 | 0 | 2.43 |
| Amplifon | 0 | 2 | 3 | 0 | 2.60 |
Option Care Health currently has a consensus price target of $29.92, suggesting a potential upside of 23.60%. Given Option Care Health’s higher possible upside, equities analysts clearly believe Option Care Health is more favorable than Amplifon.
Volatility & Risk
Option Care Health has a beta of 0.61, indicating that its stock price is 39% less volatile than the S&P 500. Comparatively, Amplifon has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500.
Earnings & Valuation
This table compares Option Care Health and Amplifon”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Option Care Health | $5.65 billion | 0.64 | $207.59 million | $1.33 | 18.20 |
| Amplifon | $2.71 billion | 0.91 | $103.33 million | $0.37 | 30.30 |
Option Care Health has higher revenue and earnings than Amplifon. Option Care Health is trading at a lower price-to-earnings ratio than Amplifon, indicating that it is currently the more affordable of the two stocks.
Summary
Option Care Health beats Amplifon on 10 of the 14 factors compared between the two stocks.
About Option Care Health
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
About Amplifon
Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices. It also operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. Amplifon S.p.A. was founded in 1950 and is headquartered in Milan, Italy. Amplifon S.p.A.
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.
